QUALITY OF LIFE ASSESSMENT IN PATIENTS WITH MYOCARDIAL INFARCTION AFTER PERCUTANEOUS CORONARY INTERVENTION

Authors:

Abstract:

The purpose of the study was to evaluate differences in quality-of-life scores using the SF-36 questionnaire in patients after myocardial infarction, according to coronary blood flow restoration during the interventional procedure, over the long-term follow-up. This observational comparative study included 152 post-myocardial infarction patients who were followed dynamically for 24 months. Patients were divided into two groups. Quality of life was assessed using the standardized SF-36 questionnaire at 6 months and at the end of the follow-up period, evaluating physical functioning, role limitations, pain intensity, general health, vitality, social functioning, role functioning due to emotional status, and mental health. The data obtained showed that six months after myocardial infarction, patients demonstrated reduced quality of life scores across all scales with partially preserved physical and social functioning. During long-term follow-up, patients with percutaneous coronary intervention showed significant improvements in physical functioning, pain intensity, general health, vitality, and social functioning compared with the same indices in patients without percutaneous coronary intervention. Psycho-emotional components also improved, though changes were less expressed. These findings indicate in favour of percutaneous coronary intervention, which contributes to better long-term quality of life outcomes, primarily by enhancing physical capacity, reducing pain, and improving subjective health perception. The authors are confident that quality-of-life evaluation using the SF-36 complements traditional clinical evaluation and enables targeted rehabilitation strategies. Integration of quality-of-life measures into post-myocardial infarction follow-up is essential to optimize patient care and recovery outcomes.

Keywords:

myocardial infarction percutaneous coronary intervention quality of life SF-36 physical functioning psycho-emotional health

References:

1. Baris RO, Tabit CE. Heart Failure Readmission Prevention Strategies-A Comparative Review of Medications, Devices, and Other Interventions. J Clin Med. 2025;14(16):5894. doi: 10.3390/jcm14165894.
2. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; 44(38): 3720-3826. doi: 10.1093/eurheartj/ehad191.
3. Coerkamp CF, Hoogewerf M, van Putte BP, Appelman Y, Doevendans PA. Revascularization strategies for patients with established chronic coronary syndrome. Eur J Clin Invest. 2022; 52(8): 13787. doi: 10.1111/eci.13787.
4. Gąsecka A, Rzepa B, Skwarek A, Ćwiek A, Pluta K, Szarpak Ł. et al. Health-related Quality of Life Increases After First-time Acute Myocardial Infarction: a Population-based Study. Zdr Varst. 2021;61(1):24-31. doi: 10.2478/sjph-2022-0005.
5. Kolarczyk E, Kohanová D, Witkowska A, Szymiczek M, Młynarska A. The factors of quality of life among patients after myocardial infarction in Poland: a cross-sectional study. The quality of life among patients after myocardial infarction. Sci Rep. 2024;14(1):15925. doi: 10.1038/s41598-024-65525-z.
6. Kucher SV, Mudra OО, Hanberher II, Mysula MS, Mysula YuI, Dzhyvak VH. et al. Investigation of increased levels of anxiety and depression impact on the quality of life in patients with irritable bowel syndrome. World Med Biol. 2025; 21(92): 89-94. doi: 10.26724/2079-8334-2025-2-92-89-94.
7. Mansilla-Chacón M, Gómez-Urquiza JL, Martos-Cabrera MB, Albendín-García L, Romero-Béjar JL, Cañadas-De La Fuente GA. et al. Effects of Supervised Cardiac Rehabilitation Programmes on Quality of Life among Myocardial Infarction Patients: A Systematic Review and Meta-Analysis. J Cardiovasc Dev Dis. 2021; 8(12): 166. doi: 10.3390/jcdd8120166.
8. McCrary JM, Altenmüller E, Kretschmer C, Scholz DS. Association of Music Interventions With Health-Related Quality of Life: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(3): 223236. doi: 10.1001/jamanetworkopen.2022.3236.
9. Siriyotha S, Pattanaprateep O, Srimahachota S, Sansanayudh N, Thakkinstian A, Limpijankit T. Factors associated with health-related quality of life in patients undergoing percutaneous coronary intervention: Thai PCI registry. Front Cardiovasc Med. 2023; 10: 1260993. doi: 10.3389/fcvm.2023.1260993.
10. Spirito A, Cangialosi P, Cao D, Nicolas J, Mehran R. Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention. Interv Cardiol Clin. 2022; 11(4): 419-428. doi: 10.1016/j.iccl.2022.02.003.
11. Tokarewicz J, Jankowiak B, Klimaszewska K, Święczkowski M, Matlak K, Dobrzycki S. Acceptance of Illness and Health-Related Quality of Life in Patients After Myocardial Infarction-Narrative Review. J Clin Med. 2025; 14(3): 729. doi: 10.3390/jcm14030729.
12. Tsoulou V, Vasilopoulos G, Kapadochos T, Pavlatou N, Kalogianni A, Toulia G. et al. Quality of Life in Patients Undergoing Percutaneous Coronary Intervention. Clin Pract. 2023; 13(3): 621-637. doi: 10.3390/clinpract13030057.
13. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA. 2025; 333(1): 71-74. doi: 10.1001/jama.2024.21972.
14. Wu L, Liu X, Tang X, Qi X, Song J, Huang W. et al. Effect of case management based on Omaha system on clinical symptoms and quality of life of coronary heart disease patients after percutaneous coronary intervention. Medicine (Baltimore). 2024; 103(26): 38553. doi: 10.1097/MD.0000000000038553.
15. Zhu M, Li Y, Xu Q, Wang W, Liu Y, Liu Y. Acute Myocardial Infarction: Molecular Pathogenesis, Diagnosis, and Clinical Management. MedComm (2020). 2025;6(10):e70418. doi: 10.1002/mco2.70418.

Publication:

«World of Medicine and Biology» Vol. 22 No. 96 (2026) , с. 77-81
УДК 616.127-005.8:616.379-008.64]+616.12-008.46

DOI:

https://doi.org/10.26724/2079-8334-2026-2-96-77-81